Impact of social media on e-cigarette use in young adults
Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach
This study is testing if cutting back on social media can help young adults who vape use e-cigarettes less.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 25 Years |
| Sex | All |
| Sponsor | University of Oklahoma Academic / other |
| Locations | 1 site (Oklahoma City, Oklahoma) |
| Trial ID | NCT06142877 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates how reducing social media use affects e-cigarette consumption among young adults aged 18-25 who currently vape. Participants will complete surveys and provide screenshots of their social media usage over a month, followed by a randomized intervention where some will reduce their social media use while others will continue as usual. The study aims to explore the relationship between social media engagement, mental health, and vaping behavior, contributing to a better understanding of how social media influences nicotine use in this demographic.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18-25 who use e-cigarettes and engage daily with social media.
Not a fit: Patients who do not use e-cigarettes or do not engage with social media may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help develop strategies to reduce e-cigarette use among young adults by addressing social media influences.
How similar studies have performed: While the relationship between social media and vaping is recognized, this specific intervention approach is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-25 * Daily social media use * Ownership of a smartphone * Vaping (i.e., use of a nicotine e-cigarette) on 1-19 days of the past 30 days * Residing in the United States Exclusion Criteria: -Lack of capacity to provide informed consent
Where this trial is running
Oklahoma City, Oklahoma
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States (Recruiting)
Study contacts
- Principal investigator: Erin A Vogel, PhD — University of Oklahoma
- Study coordinator: Erin A Vogel, PhD
- Email: erin-vogel@ouhsc.edu
- Phone: 405-271-8001
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.